These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 18025220)

  • 1. Novel structural determinants on SIRP alpha that mediate binding to CD47.
    Lee WY; Weber DA; Laur O; Severson EA; McCall I; Jen RP; Chin AC; Wu T; Gernert KM; Parkos CA
    J Immunol; 2007 Dec; 179(11):7741-50. PubMed ID: 18025220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional elements on SIRPalpha IgV domain mediate cell surface binding to CD47.
    Liu Y; Tong Q; Zhou Y; Lee HW; Yang JJ; Bühring HJ; Chen YT; Ha B; Chen CX; Yang Y; Zen K
    J Mol Biol; 2007 Jan; 365(3):680-93. PubMed ID: 17070842
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Crystal structure of signal regulatory protein gamma (SIRPγ) in complex with an antibody Fab fragment.
    Nettleship JE; Ren J; Scott DJ; Rahman N; Hatherley D; Zhao Y; Stuart DI; Barclay AN; Owens RJ
    BMC Struct Biol; 2013 Jul; 13():13. PubMed ID: 23826770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surfactant protein D (Sp-D) binds to membrane-proximal domain (D3) of signal regulatory protein α (SIRPα), a site distant from binding domain of CD47, while also binding to analogous region on signal regulatory protein β (SIRPβ).
    Fournier B; Andargachew R; Robin AZ; Laur O; Voelker DR; Lee WY; Weber D; Parkos CA
    J Biol Chem; 2012 Jun; 287(23):19386-98. PubMed ID: 22511785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human lymphocytes interact directly with CD47 through a novel member of the signal regulatory protein (SIRP) family.
    Brooke G; Holbrook JD; Brown MH; Barclay AN
    J Immunol; 2004 Aug; 173(4):2562-70. PubMed ID: 15294972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Signal-regulatory protein alpha (SIRPalpha) but not SIRPbeta is involved in T-cell activation, binds to CD47 with high affinity, and is expressed on immature CD34(+)CD38(-) hematopoietic cells.
    Seiffert M; Brossart P; Cant C; Cella M; Colonna M; Brugger W; Kanz L; Ullrich A; Bühring HJ
    Blood; 2001 May; 97(9):2741-9. PubMed ID: 11313266
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of high affinity, pan-allelic, and pan-mammalian reactive antibodies against the myeloid checkpoint receptor SIRPα.
    Sim J; Sockolosky JT; Sangalang E; Izquierdo S; Pedersen D; Harriman W; Wibowo AS; Carter J; Madan A; Doyle L; Harrabi O; Kauder SE; Chen A; Kuo TC; Wan H; Pons J
    MAbs; 2019; 11(6):1036-1052. PubMed ID: 31257988
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Paired receptor specificity explained by structures of signal regulatory proteins alone and complexed with CD47.
    Hatherley D; Graham SC; Turner J; Harlos K; Stuart DI; Barclay AN
    Mol Cell; 2008 Jul; 31(2):266-77. PubMed ID: 18657508
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Crystal Structure of Human CD47 in Complex with Engineered SIRPα.D1(N80A).
    Yu J; Li S; Chen D; Liu D; Guo H; Yang C; Zhang W; Zhang L; Zhao G; Tu X; Peng L; Liu S; Bai X; Song Y; Jiang Z; Zhang R; Tian W
    Molecules; 2022 Aug; 27(17):. PubMed ID: 36080360
    [No Abstract]   [Full Text] [Related]  

  • 10. Peptide-mediated inhibition of neutrophil transmigration by blocking CD47 interactions with signal regulatory protein alpha.
    Liu Y; O'Connor MB; Mandell KJ; Zen K; Ullrich A; Bühring HJ; Parkos CA
    J Immunol; 2004 Feb; 172(4):2578-85. PubMed ID: 14764731
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SIRPbeta1 is expressed as a disulfide-linked homodimer in leukocytes and positively regulates neutrophil transepithelial migration.
    Liu Y; Soto I; Tong Q; Chin A; Bühring HJ; Wu T; Zen K; Parkos CA
    J Biol Chem; 2005 Oct; 280(43):36132-40. PubMed ID: 16081415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Signal regulatory protein (SIRPalpha), a cellular ligand for CD47, regulates neutrophil transmigration.
    Liu Y; Bühring HJ; Zen K; Burst SL; Schnell FJ; Williams IR; Parkos CA
    J Biol Chem; 2002 Mar; 277(12):10028-36. PubMed ID: 11792697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural insight into the specific interaction between murine SHPS-1/SIRP alpha and its ligand CD47.
    Nakaishi A; Hirose M; Yoshimura M; Oneyama C; Saito K; Kuki N; Matsuda M; Honma N; Ohnishi H; Matozaki T; Okada M; Nakagawa A
    J Mol Biol; 2008 Jan; 375(3):650-60. PubMed ID: 18045614
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel SIRPα Antibodies That Induce Single-Agent Phagocytosis of Tumor Cells while Preserving T Cells.
    Andrejeva G; Capoccia BJ; Hiebsch RR; Donio MJ; Darwech IM; Puro RJ; Pereira DS
    J Immunol; 2021 Feb; 206(4):712-721. PubMed ID: 33431660
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selection and Characterization of FD164, a High-Affinity Signal Regulatory Protein
    Wang Z; Hu N; Li X; Wang H; Ren C; Qiao C; Chen G; Wang J; Zhou L; Wu J; Zhang D; Feng J; Shen B; Peng H; Luo L
    Mol Pharmacol; 2021 Sep; 100(3):193-202. PubMed ID: 34315811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of cis dimerization of signal regulatory protein alpha (SIRPalpha) in binding to CD47.
    Lee WY; Weber DA; Laur O; Stowell SR; McCall I; Andargachew R; Cummings RD; Parkos CA
    J Biol Chem; 2010 Dec; 285(49):37953-63. PubMed ID: 20826801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Signal regulatory proteins in the immune system.
    van Beek EM; Cochrane F; Barclay AN; van den Berg TK
    J Immunol; 2005 Dec; 175(12):7781-7. PubMed ID: 16339510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BYON4228 is a pan-allelic antagonistic SIRPα antibody that potentiates destruction of antibody-opsonized tumor cells and lacks binding to SIRPγ on T cells.
    van Helden MJ; Zwarthoff SA; Arends RJ; Reinieren-Beeren IMJ; Paradé MCBC; Driessen-Engels L; de Laat-Arts K; Damming D; Santegoeds-Lenssen EWH; van Kuppeveld DWJ; Lodewijks I; Olsman H; Matlung HL; Franke K; Mattaar-Hepp E; Stokman MEM; de Wit B; Glaudemans DHRF; van Wijk DEJW; Joosten-Stoffels L; Schouten J; Boersema PJ; van der Vleuten M; Sanderink JWH; Kappers WA; van den Dobbelsteen D; Timmers M; Ubink R; Rouwendal GJA; Verheijden G; van der Lee MMC; Dokter WHA; van den Berg TK
    J Immunother Cancer; 2023 Apr; 11(4):. PubMed ID: 37068796
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Binding Mechanism of CD47 with SIRPα Variants and Its Antibody: Elucidated by Molecular Dynamics Simulations.
    Huang K; Liu Y; Wen S; Zhao Y; Ding H; Liu H; Kong DX
    Molecules; 2023 Jun; 28(12):. PubMed ID: 37375166
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting the myeloid checkpoint receptor SIRPα potentiates innate and adaptive immune responses to promote anti-tumor activity.
    Kuo TC; Chen A; Harrabi O; Sockolosky JT; Zhang A; Sangalang E; Doyle LV; Kauder SE; Fontaine D; Bollini S; Han B; Fu YX; Sim J; Pons J; Wan HI
    J Hematol Oncol; 2020 Nov; 13(1):160. PubMed ID: 33256806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.